about
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cellular therapy product candidates and gamma-delta T cell engagers (TCEs) for cancer and autoimmune diseases. Gamma...
Read More
1.32
-0.06
(-4.35%)
54,803.8
XNAS Volume
XNAS 17 Jul, 2026 12:31 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
IN8bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..